Active, Not Recruiting
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B
NCT07135349
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Argo Investigative Site Hefei, Anhui, China
- Argo Investigative Site Beijing, Beijing Municipality, China
- Argo Investigative Site Sichuan, Chengdu, China
- Argo Investigative Site Chongqing, Chongqing Municipality, China